Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review

por Blumenfeld, Andrew M., Kaur, Gavneet, Mahajan, Anadi, Shukla, Hemlata, Sommer, Katherine, Tung, Amy, Knievel, Kerry L.
Publicado 2022

Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials

por Blumenfeld, Andrew M., Knievel, Kerry, Manack Adams, Aubrey, Severt, Lawrence, Butler, Matthew, Lai, Hongxin, Dodick, David W.
Publicado 2021

Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans

por Knievel, Kerry, Buchanan, Andrew S, Lombard, Louise, Baygani, Simin, Raskin, Joel, Krege, John H, Loo, Li Shen, Komori, Mika, Tobin, Joshua
Publicado 2019

Long‐Term Safety Evaluation of Ubrogepant for the Acute Treatment of Migraine: Phase 3, Randomized, 52‐Week Extension Trial

por Ailani, Jessica, Lipton, Richard B., Hutchinson, Susan, Knievel, Kerry, Lu, Kaifeng, Butler, Matthew, Yu, Sung Yun, Finnegan, Michelle, Severt, Lawrence, Trugman, Joel M.
Publicado 2020

Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study

por Cowan, Robert P., Rapoport, Alan M., Blythe, Jim, Rothrock, John, Knievel, Kerry, Peretz, Addie M., Ekpo, Elizabeth, Sanjanwala, Bharati M., Woldeamanuel, Yohannes W.
Publicado 2022